Biovet AD

Newsletters

TOPICS

COUNTRIES

INDUSTRY

LOGIN

Companies

Biovet AD

Country

Bulgaria

Industry

Pharmaceuticals

Owner

Huvepharma AD

Assets

1,091,025,000

Currency

BGN

Year

2024

Profit

118,902,000

Revenue

615,755,000

Employees

2,395

FULL COMPANY PROFILE

Latest news

Bulgaria's Biovet could start production of COVID-19 vaccines in June - PM

Mar 22, 2021

March 22 (SeeNews) - Bulgarian drug maker Biovet is investing 120 million levs ($73.2 million/61.4 million euro) in a new production line which will be able to start production of COVID-19 vaccines in June, prime minister Boyko Borissov said.

Bulgaria's Biovet investing 204.5 mln euro in new plant - econ min

Mar 17, 2021

Bulgaria's Biovet, Huvepharma to seek 115 mln euro in loans from EIB, private lenders

Jul 24, 2020

Bulgaria's Biovet opens 150 mln euro production plant - govt

Sep 16, 2019

Bulgaria's Biovet lifts 2018 net profit on rise in revenue

Jul 9, 2019

all stories about the company

more for country

more for top100

more for this industry

Your complete guide to the emerging economies of Southeast Europe. From latest news to bespoke research – the big picture at the tip of your fingers.

About

SeeNews is your complete guide to the emerging economies of Southeast Europe. Latest news, market intelligence, industry analyses, on-demand research – the big picture at the tip of your fingers.

More about SeeNews

Premium access

Get ahead of the competition with SeeNews Premium Access. Unlimited news and objective analysis you can trust, company data and more. Subscribe now and start making agile business decisions.